Frederick Richards

3.2k total citations
100 papers, 2.5k citations indexed

About

Frederick Richards is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Frederick Richards has authored 100 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 18 papers in Epidemiology. Recurrent topics in Frederick Richards's work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (18 papers) and Cancer Treatment and Pharmacology (17 papers). Frederick Richards is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (18 papers) and Cancer Treatment and Pharmacology (17 papers). Frederick Richards collaborates with scholars based in United States, Canada and United Kingdom. Frederick Richards's co-authors include Charles L. Spurr, M. Robert Cooper, Dougľas R. White, Hyman B. Muss, Don V. Jackson, John J. Stuart, L. Douglas Case, Robert L. Capizzi, Bayard L. Powell and David H. Buss and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Frederick Richards

100 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick Richards United States 29 1.2k 497 457 446 372 100 2.5k
Charles L. Spurr United States 28 1.0k 0.9× 470 0.9× 394 0.9× 299 0.7× 308 0.8× 107 2.6k
Louis A. Leone United States 26 1.2k 1.0× 582 1.2× 352 0.8× 208 0.5× 158 0.4× 59 2.4k
Don V. Jackson United States 27 1.3k 1.1× 508 1.0× 337 0.7× 168 0.4× 216 0.6× 75 2.0k
Carlos D. Flombaum United States 24 749 0.6× 642 1.3× 590 1.3× 246 0.6× 128 0.3× 40 2.2k
F. Cavalli Switzerland 33 2.2k 1.8× 660 1.3× 705 1.5× 369 0.8× 444 1.2× 147 4.0k
Gerardo Colón‐Otero United States 30 2.0k 1.7× 608 1.2× 595 1.3× 407 0.9× 290 0.8× 99 3.5k
Glenn Mills United States 26 1.9k 1.6× 930 1.9× 673 1.5× 428 1.0× 216 0.6× 119 3.4k
Lawrence S. Lessin United States 25 630 0.5× 188 0.4× 305 0.7× 421 0.9× 458 1.2× 61 2.0k
Ralph Levitt United States 27 2.1k 1.8× 892 1.8× 670 1.5× 348 0.8× 523 1.4× 67 3.6k
H. Anderson Sweden 28 1.4k 1.2× 603 1.2× 254 0.6× 142 0.3× 127 0.3× 51 2.8k

Countries citing papers authored by Frederick Richards

Since Specialization
Citations

This map shows the geographic impact of Frederick Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Richards more than expected).

Fields of papers citing papers by Frederick Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Richards. The network helps show where Frederick Richards may publish in the future.

Co-authorship network of co-authors of Frederick Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick Richards. A scholar is included among the top collaborators of Frederick Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick Richards. Frederick Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kilpatrick, Scott E., et al.. (1998). Epithelioid hemangioendothelioma of bone and soft tissue: A fine-needle aspiration biopsy study with histologic and immunohistochemical confirmation. Diagnostic Cytopathology. 19(1). 38–43. 26 indexed citations
2.
3.
Muss, Hyman B., L. Douglas Case, Frederick Richards, et al.. (1991). Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast Cancer. New England Journal of Medicine. 325(19). 1342–1348. 131 indexed citations
4.
Muss, Hyman B., L. Douglas Case, Robert L. Capizzi, et al.. (1990). High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.. Journal of Clinical Oncology. 8(11). 1797–1805. 61 indexed citations
5.
White, Dougľas R., Bayard L. Powell, Robert K. Stuart, et al.. (1990). A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A piedmont oncology association study. Cancer. 65(8). 1700–1703. 5 indexed citations
6.
Jackson, Don V., Marcus E. Randall, & Frederick Richards. (1988). Spinal cord compression due to extramedullary hematopoiesis in thalassemia: Long-term follow-up after radiotherapy. Surgical Neurology. 29(5). 389–392. 47 indexed citations
7.
Powell, Bayard L., et al.. (1988). Phase I–II trial of acivicin in adult acute leukemia. Investigational New Drugs. 6(1). 41–44. 6 indexed citations
8.
Powell, Bayard L., Don V. Jackson, Charles W. Scarantino, et al.. (1985). Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis. International Journal of Radiation Oncology*Biology*Physics. 11(3). 457–462. 10 indexed citations
9.
Richards, Frederick, et al.. (1984). Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause.. BMJ. 289(6441). 343–345. 46 indexed citations
10.
Jackson, Don V., et al.. (1984). Hepatic intra-arterial infusion of vincristine. Cancer Chemotherapy and Pharmacology. 13(2). 120–122. 1 indexed citations
11.
Muss, Hyman B., John J. Stuart, Don V. Jackson, et al.. (1984). Bone marrow evaluation in small cell lung cancer. American Journal of Clinical Oncology. 7(1). 59–64. 7 indexed citations
12.
Cooper, M. Robert, Thomas F. Pajak, Nis I. Nissen, et al.. (1982). Effect of the methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease. Cancer. 49(11). 2226–2230. 5 indexed citations
13.
Muss, Hyman B., Frederick Richards, M. Robert Cooper, et al.. (1982). Nonseminomatous germ cell cancer of the testis. Reducing treatment-related morbidity in patients with disseminated disease. Cancer. 50(9). 1742–1745. 4 indexed citations
14.
15.
Richards, Frederick, M. Robert Cooper, Dougľas R. White, et al.. (1980). Advanced epidermoid lung cancer. Prolonged survival after chemotherapy. Cancer. 46(1). 34–37. 2 indexed citations
16.
Richards, Frederick, et al.. (1978). The control of chronic lymphocytic leukemia with mediastinal irradiation. The American Journal of Medicine. 64(6). 947–954. 11 indexed citations
17.
Muss, Hyman B., Dougľas R. White, Frederick Richards, et al.. (1978). Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial. Cancer. 42(5). 2141–2148. 73 indexed citations
18.
Haid, Max, et al.. (1977). Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 50(1). 103–5. 7 indexed citations
19.
Hb, Muss, et al.. (1976). Adriamycin and CCNU in the treatment of advanced breast cancer.. PubMed. 60(11). 1687–9. 7 indexed citations
20.
Konrad, Patricia N., Frederick Richards, William N. Valentine, & Donald E. Paglia. (1972). γ-Glutamyl-Cysteine Synthetase Deficiency. New England Journal of Medicine. 286(11). 557–561. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles L. Spurr Breakdown of academic impact, for papers by Louis A. Leone Breakdown of academic impact, for papers by Don V. Jackson Breakdown of academic impact, for papers by Carlos D. Flombaum Breakdown of academic impact, for papers by F. Cavalli Breakdown of academic impact, for papers by Gerardo Colón‐Otero Breakdown of academic impact, for papers by Glenn Mills Breakdown of academic impact, for papers by Lawrence S. Lessin Breakdown of academic impact, for papers by Ralph Levitt Breakdown of academic impact, for papers by H. Anderson
Rankless by CCL
2026